ALKS-33: Clinical Trials

2 trials of ALKS-33, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow ALKS-33: new trials by email Literature Review of ALKS-33 trials Research Report on ALKS-33

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
RDC-0313 + Buprenorphine, Placebo - Substance-Related Disorders
Phase 1CompletedNational Institute on Drug Abuse (NIDA)122010-01-012017-01-11
ALK33-001: A Study of RDC-0313 Administered to Healthy Adults
RDC-0313, Placebo - Alcohol Dependence
Phase 1CompletedAlkermes, Inc.162008-12-012011-08-22

Conditions studied

Alcoholism (1)  ·  Substance-Related Disorders (1)

Sponsors

Alkermes, Inc. (1)  ·  National Institute on Drug Abuse (NIDA) (1)

Countries

United States (2)

Top investigators

Philip T. Leese, MD (1)

Results publications

PMID 25456560